论文部分内容阅读
消化道出血是慢性肺心病的严重并发症,发生率高,预后恶劣。为预防出血,提高其存活率,本文观察82例肺心病患者,应用和不用H_2受体拮抗剂H_2—RB),对消化道出血的影响。 1 临床资料 82例肺心病患者分为两组。甲组用H_2—RB,30例,其中男18例,女12例,年龄35~82岁。平均60.3±18.2岁。乙组不用H_2—RB,52例,其中男32例,女20例,年龄34~80岁,平均63.2±12.2岁。全部病例均符合1977年全国肺心病专业会议的诊断标准。
Gastrointestinal bleeding is a serious complication of chronic pulmonary heart disease, the incidence is high, the prognosis is poor. In order to prevent bleeding and improve its survival rate, this article observed 82 patients with pulmonary heart disease, with and without H 2 receptor antagonist H_2-RB), the impact of gastrointestinal bleeding. 1 clinical data 82 cases of pulmonary heart disease patients are divided into two groups. A group with H_2-RB, 30 cases, 18 males and 12 females, aged 35 to 82 years. Average 60.3 ± 18.2 years old. In group B, there were 52 cases without H_2-RB, including 32 males and 20 females, aged from 34 to 80 years (average 63.2 ± 12.2 years). All cases are in line with the National Conference of Pulmonary Heart Disease in 1977 diagnostic criteria.